Saturday, November 21, 2026
News

Sun Pharma, SPARC sign licence agreement for sale of seizure drug for injection in US

SocialTwist Tell-a-Friend    Print this Page   COMMENT

Mumbai (Maharashtra) | November 9, 2022 6:59:47 PM IST
Mumbai-based Sun Pharma, including its subsidiaries, and Sun Pharma Advanced Research Company (SPARC) on Wednesday announced the signing of a licensing agreement for commercialisation of benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection in the US.

SPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for this product for the treatment of seizures in newborns in February 2022, according to Sun Pharma statement shared with stock exchanges. Sun Pharma is a wholly-owned subsidiary of Sun Pharmaceutical Industries.

Currently, there are no phenobarbital injection products approved by the US FDA for the treatment of seizures in newborns.

Under the terms of the licence agreement, Sun Pharma will pay SPARC an upfront payment of $10 million. SPARC will also be eligible to receive milestone payments contingent upon the achievement of regulatory and sales milestones, as well as tiered royalties on sales.

"SPARC's benzyl alcohol and propylene glycol-free formulation of phenobarbital for injection is an exciting addition to our growing portfolio of specialty branded products in the US. Through our existing relationships with hospitals and other institutional customers, we are well-positioned to bring this product to market and make a difference in the lives of patients," said Abhay Gandhi, CEO North America, Sun Pharma.

SPARC CEO Anil Raghavan said, "SPARC is excited to enter into this collaboration with Sun Pharma and is committed to developing new products to address the needs of patients. SPARC's benzyl alcohol and propylene glycol-free formulation of phenobarbital for injection is designed to minimise the risk of neonatal gasping syndrome, a life-threatening condition, which can be observed with the use of benzyl alcohol-containing drug formulations." (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Indian-Origin, US-Based Agency Founder N...
Sloan Announces Strategic Partnership wi...
Antariksh Venture Capital Fund Leads Sat...
Surya Star Chef Season 2 to Showcase Sur...
BML Munjal University Marks Founder's Da...
Soch Partners with OneConsent to Impleme...
More...
 
INDIA WORLD ASIA
CCMB scientists identify two Genes that ...
303 fugitives from 36 countries brought ...
Beyond tourism, Goa is ready for global ...
Will Chandni Chowk finally get relief fr...
Lok Sabha Speaker Om Birla condoles demi...
6th Anti-Terror Conference concludes wit...
More...    
 
 Top Stories
Unadkat's hat-trick, Juyal's blitz ... 
"They've been bullsh***ing people f... 
"Believe there is potential for mor... 
Sandesh Shrivastava assumes charge ... 
Tripura Election Commission reviews... 
Taylor Swift named International Ar... 
"Pakistan only 80 years away from u... 
From the shadow of Naxalism to the ...